Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Incretins].

J Vrbíková1, K Vondra

  • 1Endokrinologický ustav, Praha. jvrbikova@endo.cz

Vnitrni Lekarstvi
|October 27, 2006
PubMed
Summary
This summary is machine-generated.

The incretin effect enhances insulin secretion after oral glucose intake compared to intravenous. Key incretins, glucagon-like peptide 1 and glucose-dependent insulinotropic peptide, are vital in metabolic health and disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Postprandial Triglyceride, Glucose and Insulin Levels 10 Years After Bariatric Surgery in Women With Severe Obesity - A Pilot Study: Part 1 - Laparoscopic Greater Curvature Plication.

Physiological research·2023
Same author

Postprandial Triglyceride, Glucose and Insulin Levels 10 Years After Bariatric Surgery in Women With Severe Obesity - A Pilot Study: Part 2 - Biliopancreatic Diversion.

Physiological research·2023
Same author

Endocrine disruptors, obesity, and cytokines - how relevant are they to PCOS?

Physiological research·2020
Same author

The gold standard of thyroid nodule examination? Prospective validation of the ACR TI-RADS in a secondary referral center.

Physiological research·2020
Same author

Genetic predictors of the development and recurrence of Graves' disease.

Physiological research·2018
Same author

Diagnostic pitfalls in ovarian androgen-secreting (Leydig cell) tumours: case series.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2018
Same journal

Pharmacological profile of mepolizumab.

Vnitrni lekarstvi·2023
Same journal

Atypical form of Goodpasture's disease.

Vnitrni lekarstvi·2023
Same journal

Differentiated thyroid cancer - possible risks of treatment, suppressive therapy and adherence to current recommendations.

Vnitrni lekarstvi·2023
Same journal

Dyslipidemia - the known unknown.

Vnitrni lekarstvi·2023
Same journal

Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!

Vnitrni lekarstvi·2023
Same journal

Implications of highly suppressive treatment HIV infection.

Vnitrni lekarstvi·2023
See all related articles

Area of Science:

  • Endocrinology
  • Metabolic Physiology
  • Pharmacology

Background:

  • The incretin effect describes the phenomenon where oral glucose elicits a greater insulin response than intravenous glucose.
  • Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) are the primary incretin hormones responsible for this effect.
  • Incretins play a crucial role in glucose homeostasis and have implications beyond diabetes.

Purpose of the Study:

  • To explore the physiological basis of the incretin effect.
  • To discuss the pathophysiology involving incretins in metabolic and neurological conditions.
  • To examine the therapeutic potential of incretins in various diseases.

Main Methods:

  • Review of existing literature on incretin physiology and function.

Related Experiment Videos

  • Analysis of studies investigating incretin roles in diabetes and neurodegenerative disorders.
  • Examination of clinical data related to incretin-based therapies.

    • Main Results:

    • Oral glucose administration stimulates significantly higher insulin secretion compared to intravenous administration, mediated by incretins.
    • GLP-1 and GIP levels and activity are altered in conditions like type 2 diabetes and stress hyperglycemia.
    • Incretin-based therapies show promise for managing diabetes and potentially other conditions.

    Conclusions:

    • The incretin effect is a fundamental aspect of glucose metabolism, primarily driven by GLP-1 and GIP.
    • Dysregulation of incretin pathways contributes to the pathophysiology of diabetes and other disorders.
    • Targeting incretin pathways offers a significant therapeutic avenue for metabolic and potentially neurodegenerative diseases.